Abstract
Leishmaniasis is an important parasitic disease, and definite diagnosis using a specific and sensitive method is the first step to cure the disease. Here, we present a novel diagnostic strategy based on serum peptide profiling by magnetic beads and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The serum peptides from the Leishmani donovani-infected and healthy mice were enriched by the optimized magnetic beads. The mass spectrograms were acquired by MALDI-TOF MS and analyzed by the ClinProTools bioinformatics software from Bruker Daltonics. The diagnostic model of serum peptide profiling produced by the ClinProTools software could correctly detect L. donovani infection in mice from the third day post-infection, with the accuracy of 94.1%, sensitivity of 92.4%, and specificity of 97.1%, respectively. The results of the present study suggested that the serum peptide profiling by MALDI-TOF MS is a novel potential tool for the clinical diagnosis of leishmaniasis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.